Join
Live feed
·
PRReleasevia Quantisnow
BioCardia Inc. logo

BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort

ByQuantisnow·Wall Street's wire, on your screen.
BCDA· BioCardia Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCDA (BioCardia Inc.) and more on Quantisnow.